Silvana Konermann is Co-Founder, Executive Director, and Core Investigator at Arc Institute, and an Assistant Professor of Biochemistry at Stanford University. Her research uses functional genomics, CRISPR, and RNA-targeting technologies to study neurodegenerative disease, including Alzheimer’s disease.
Silvana Konermann is Co-Founder, Executive Director, and Core Investigator at Arc Institute, and an Assistant Professor of Biochemistry at Stanford University. Her research uses functional genomics, CRISPR, and RNA-targeting technologies to study neurodegenerative disease, including Alzheimer’s disease.